Monoamine Oxidase Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monoamine Oxidase Inhibitor, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19